Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 11 Dec 2025 – 20 Aug 2026, limited by DSP Nifty Smallcap 250 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Nifty Smallcap 250 Index Fund | Nifty Smallcap 250 |
|---|---|---|
| 11 Dec 2025 | ₹100.00 | ₹100.00 |
| 01 Jan 2026 | ₹102.42 | ₹102.50 |
| 22 Jan 2026 | ₹95.94 | ₹96.05 |
| 12 Feb 2026 | ₹99.75 | ₹99.93 |
| 05 Mar 2026 | ₹94.91 | ₹95.11 |
| 26 Mar 2026 | ₹91.59 | ₹91.86 |
| 16 Apr 2026 | ₹99.32 | ₹99.62 |
| 07 May 2026 | ₹106.63 | ₹107.06 |
| 28 May 2026 | ₹104.71 | ₹105.18 |
| 18 Jun 2026 | ₹107.78 | ₹108.31 |
| 09 Jul 2026 | ₹109.34 | ₹109.93 |
| 30 Jul 2026 | ₹109.28 | ₹109.74 |
| 20 Aug 2026 | ₹112.32 | ₹112.77 |
| Metric | DSP · Regular NAV ₹11.23 Very High risk Unrated | Category median Index Funds · 366 funds |
|---|---|---|
| — | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +12.32% | +7.40% | |
| +34.04% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 18.94% | 13.88% | |
| — | 0.25 | |
| — | 0.35 | |
| -15.63% | -16.66% | |
| Nifty Smallcap 250 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.28% | 0.96% | |
| ₹11.32Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 50% | 35% | |
| Anil Ghelani | — | |
| 11 Dec 2025 | — | |
| 250 | — | |
| 11.5% | — | |
| -0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.